Angiodynamics (ANGO) Research & Development (2016 - 2025)
Historic Research & Development for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $7.8 million.
- Angiodynamics' Research & Development rose 2073.36% to $7.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $27.7 million, marking a year-over-year increase of 20.27%. This contributed to the annual value of $26.2 million for FY2025, which is 1678.73% down from last year.
- Angiodynamics' Research & Development amounted to $7.8 million in Q4 2025, which was up 2073.36% from $6.4 million recorded in Q3 2025.
- In the past 5 years, Angiodynamics' Research & Development registered a high of $9.1 million during Q2 2021, and its lowest value of $6.3 million during Q3 2024.
- Over the past 5 years, Angiodynamics' median Research & Development value was $7.6 million (recorded in 2021), while the average stood at $7.5 million.
- As far as peak fluctuations go, Angiodynamics' Research & Development surged by 2661.6% in 2023, and later tumbled by 2568.72% in 2024.
- Over the past 5 years, Angiodynamics' Research & Development (Quarter) stood at $8.2 million in 2021, then fell by 16.6% to $6.8 million in 2022, then increased by 26.62% to $8.7 million in 2023, then decreased by 25.69% to $6.4 million in 2024, then rose by 20.73% to $7.8 million in 2025.
- Its Research & Development was $7.8 million in Q4 2025, compared to $6.4 million in Q3 2025 and $6.6 million in Q2 2025.